PAUSE

Item 7 lays out a hefty initial investment of $880,600-$1,534,900, including the $60,000 franchise fee, driven by buildouts for flotation tanks, saunas, and therapy suites in clean, modern spaces. Ongoing fees bite at 7% royalty plus 1% brand fund, plus fixed $3,500 monthly local marketing and $800 technology charges—a structure demanding strong local draw in the competitive health optimization arena targeting active adults. With only 3 franchise and 5 corporate locations, the system's youth shows in 9 SBA loans averaging $1,212,878, signaling lender confidence despite the premium entry.

Item 19 shines brightest: average gross revenue hits $1,542,376, median $1,569,015 across units, with estimated profits ranging $29,922-$337,410—top performers thriving on memberships and multi-packs for stress relief and athletic recovery. Projected 95 new units underscore aggressive expansion, but low unit count means unproven scalability; transfers or terminations aren't detailed, urging scrutiny of operations in saturated spa markets. For investors eyeing wellness booms, PAUSE's revenue punch justifies the outlay if you nail affluent, health-obsessed locales—just verify local demand matches those fat margins.